Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 3
2007 2
2009 5
2010 3
2011 5
2012 11
2013 19
2014 14
2015 20
2016 16
2017 9
2018 11
2019 12
2020 22
2021 25
2022 9
2023 7
2024 8
2025 15
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and treatment of radiation induced pneumonitis in patients with lung cancer: An ESTRO clinical practice guideline.
Ruysscher D, Wauters E, Jendrossek V, Filippi AR, Revel MP, Faivre-Finn C, Naidoo J, Ramella S, Guckenberger M, Ricardi U, Khalil A, Schor M, Bartolomeo V, Putora PM. Ruysscher D, et al. Among authors: filippi ar. Radiother Oncol. 2025 Jun;207:110837. doi: 10.1016/j.radonc.2025.110837. Epub 2025 Apr 2. Radiother Oncol. 2025. PMID: 40185160 Free article. Review.
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, Smit HJM, Peters S, Field JK, Christoph DC, Sibille A, Fietkau R, Haakensen VD, Chouaid C, Markman B, Hiltermann TJN, Taus A, Sawyer W, Allen A, Chander P, Licour M, Solomon B. Girard N, et al. Among authors: filippi ar. J Thorac Oncol. 2023 Feb;18(2):181-193. doi: 10.1016/j.jtho.2022.10.003. Epub 2022 Oct 25. J Thorac Oncol. 2023. PMID: 36307040 Free article.
MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB-IIIB NSCLC.
Reck M, Nadal E, Girard N, Filippi AR, Martin LW, Gay CM, Petersen C, Gale D, Emeribe UA, Georgoulia N, Perez IED, Spicer JD. Reck M, et al. Among authors: filippi ar. Clin Lung Cancer. 2024 Sep;25(6):587-593.e3. doi: 10.1016/j.cllc.2024.06.007. Epub 2024 Jun 21. Clin Lung Cancer. 2024. PMID: 39003185 Free article.
Editorial: Imaging assessment of response to immunotherapy.
Occhipinti M, Filippi AR, Walsh S, van Meerbeeck JP. Occhipinti M, et al. Among authors: filippi ar. Front Oncol. 2023 Jan 20;12:1116315. doi: 10.3389/fonc.2022.1116315. eCollection 2022. Front Oncol. 2023. PMID: 36741725 Free PMC article. No abstract available.
Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI.
Messana G, Bortolotto C, Thulasi Seetha S, Marrocco A, Pairazzi C, Sanvito F, Brero F, Robustelli Test A, Cabini RF, Lascialfari A, Zacà D, Stella GM, Agustoni F, Saddi J, Filippi AR, Preda L. Messana G, et al. Among authors: filippi ar. Eur Radiol. 2025 Sep;35(9):5569-5580. doi: 10.1007/s00330-025-11524-1. Epub 2025 Mar 27. Eur Radiol. 2025. PMID: 40146425 Free PMC article.
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
Brandão M, Prisciandaro E, Xenophontos E, Mariolo A, Sadeghi AH, Filippi AR, Levy A, Bandura A, Caramella C, Dickhoff C, de Margerie-Mellon C, Faivre-Finn C, Portik D, Sanchez-Lorente D, De Ruysscher D, Smit E, Gobbini E, Fadel E, Ruffini E, Olmetto E, Cortiula F, Bahce I, Houda I, Opitz I, Naidoo J, Edwards J, Remon J, Benitez JC, Trujillo JC, Derks J, Amrane K, Hartemink KJ, Stathopoulos K, Hendriks LEL, Iglesias M, Occhipinti M, Guckenberger M, Giaj Levra N, Girard N, Reguart N, Mercier O, Bironzo P, Hofman P, Petersen RH, De Angelis R, Abgral R, Terrisse S, Popat S, Pierret T, Blum TG, Ricardi U, Dionisi V, Berghmans T, Dingemans AC; European Organisation for Research, Treatment of Cancer EORTC Lung Cancer Group. Brandão M, et al. Among authors: filippi ar. Lung Cancer. 2025 Nov;209:108798. doi: 10.1016/j.lungcan.2025.108798. Epub 2025 Oct 14. Lung Cancer. 2025. PMID: 41108881
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R.
Filippi AR, Bar J, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, Haakensen VD, Kao S, Markman B, McDonald F, Mornex F, Moskovitz M, Peters S, Sibille A, Siva S, van den Heuvel M, Vercauter P, Anand S, Chander P, Licour M, de Lima AR, Qiao Y, Girard N. Filippi AR, et al. ESMO Open. 2024 Jun;9(6):103464. doi: 10.1016/j.esmoop.2024.103464. Epub 2024 Jun 3. ESMO Open. 2024. PMID: 38833971 Free PMC article.
An integrated approach to cardioprotection in lymphomas.
Maraldo MV, Levis M, Andreis A, Armenian S, Bates J, Brady J, Ghigo A, Lyon AR, Manisty C, Ricardi U, Aznar MC, Filippi AR. Maraldo MV, et al. Among authors: filippi ar. Lancet Haematol. 2022 Jun;9(6):e445-e454. doi: 10.1016/S2352-3026(22)00082-5. Epub 2022 May 2. Lancet Haematol. 2022. PMID: 35512725 Review.
194 results